Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed diagnosis of invasive breast cancer (adenocarcinoma type), proven by biopsy.
- People whose tumor falls within a certain size range (stages T1 to T4b — confirm with trial site for what this means in your situation).
- People whose cancer has not spread extensively to the lymph nodes (nodal stage N0 to N2 — confirm with trial site).
- People who are considered to be in generally good health or have only mild health conditions, as assessed by a standard medical classification system (ASA class I–II).
Who may not be able to join:
- People who have chosen, or been advised by their doctor, to have a mastectomy (full breast removal).
- People who have chosen, or been advised by their doctor, to have surgery as the first treatment (rather than another approach first).
- People whose cancer has spread to other parts of the body (metastatic cancer).
- People who have tumours in multiple separate areas of the breast (multifocal tumours).
- People diagnosed with lobular neoplasia (a specific type of breast tissue change — confirm with trial site).
- People who are currently pregnant or who have been pregnant within the last 6 months before enrolling.
- People currently being treated for, or living with, a second active cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +2010 9981 5110
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Local recurrence rate.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.